Bibliography
- Moens S, Vanderleyden J. Glycoproteins in prokaryotes. Arch Microbiol 1997;168:169-75
- Benz I, Schmidt MA. Never say never again: protein glycosylation in pathogenic bacteria. Mol Microbiol 2002;21:267-76
- Upreti RK, Kumar M, Shankar V. Bacterial glycoproteins: functions, biosynthesis and applications. Proteomics 2003;3:363-79
- Taupin P, Ray J, Fischer WH, FGF-2-responsive neural stem cell proliferation requires CCg, a novel autocrine/paracrine cofactor. Neuron 2000;28:385-97
- Taupin P. Ex vivo fucosylation to improve the engraftment capability and therapeutic potential of human cord blood stem cells. Drug Discov Today 2010;15:698-9
- Taupin P. Transplantation of cord blood stem cells for treating hematologic diseases and strategies to improve engraftment. Therapy 2010;7:703-15
- Moriwaki K, Miyoshi E. Fucosylation and gastrointestinal cancer. World J Hepatol 2010;2:151-61
- Miyoshi E, Moriwaki K, Nakagawa T. Biological function of fucosylation in cancer biology. J Biochem 2008;143:725-9
- Weninger W, Ulfman LH, Cheng G, Specializedcontributions by a(1,3)-fucosyltransferase-IV and FucT-VII during leukocyte rolling in dermal microvessels. Immunity 2000;12:665-76
- Taupin P. Ex vivo fucosylation of stem cells to improve engraftment: WO2004094619. Expert Opin Ther Patents 2010;20:1265-9
- Becker DJ, Lowe JB. Fucose: biosynthesis and biological function in mammals. Glycobiology 2003;13:41R-53R
- Huhn C, Selman MH, Ruhaak LR, IgG glycosylation analysis. Proteomics 2009;9:882-913
- Taupin P. Antibodies against CD20 (Rituximab) for treating multiple sclerosis: US 20100233121. Expert Opin Ther Patents 2011;21(1):111-14
- Masuda A, Yoshida M, Shiomi H, Role of Fc Receptors as a therapeutic target. Inflamm Allergy Drug Targets 2009;8:80-6
- Taupin P. Hybrid proteins comprising the constant region of immunoglobulins for treating haemophilia B. Expert Opin Ther Patents 2011; In press
- Jefferis R. Antibody therapeutics: isotype and glycoform selection. Expert Opin Biol Ther 2007;7:1401-13
- Reitman ML, Trowbridge IS, Kornfeld S. Mouse lymphoma cell lines resistant to pea lectin are defective in fucose metabolism. J Biol Chem 1980;255:9900-6
- Reitman ML, Trowbridge IS, Kornfeld S. A lectin-resistant mouse lymphoma cell line is deficient in glucosidase II, a glycoprotein-processing enzyme. J Biol Chem 1982;257:10357-63
- Malphettes L, Freyvert Y, Chang J, Highly efficient deletion of FUT8 in CHO cell lines using zinc-finger nucleases yields cells that produce completely nonfucosylated antibodies. Biotechnol Bioeng 2010;106:774-83